RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway

被引:0
|
作者
Kailiang Qiao
Yantao Liu
Zheng Xu
Haohao Zhang
Heng Zhang
Chao Zhang
Zhi Chang
Xinyan Lu
Zhongwei Li
Ce Luo
Yanrong Liu
Cheng Yang
Tao Sun
机构
[1] Nankai University,State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy
[2] Tianjin International Joint Academy of Biomedicine,Tianjin Key Laboratory of Molecular Drug Research
[3] Jining Medical University,Department of Pathology, Affiliated Hospital of Jining Medical University
来源
Angiogenesis | 2021年 / 24卷
关键词
Metastasis; Vasculogenic mimicry; N6-methyladenosine; METTL3; YAP1;
D O I
暂无
中图分类号
学科分类号
摘要
Vasculogenic mimicry (VM) formed by aggressive tumor cells to mimic vasculogenic networks plays an important role in the tumor malignancy of HCC. However, the pathogenesis underlying VM is complex and has not been fully defined. m6A is a common mRNA modification and has many biological effects. However, the relationship between m6A and VM remains unclear. In this research, we found that m6A methyltransferase METTL3 in HCC tissues was positively correlated with VM. The m6A level of mRNA significantly increased in 3D cultured cells treated with VEGFa and was related to VM formation. Transcriptome sequencing analysis of 3D cultured cells with knockdown Mettl3 showed that the Hippo pathway was involved in m6A-mediated VM formation. Further mechanism research indicated that the m6A modification of YAP1 mRNA affected the translation of YAP1 mRNA. In conclusion, m6A methylation plays a key role in VM formation in HCC. METTL3 and YAP1 could be potential therapeutic targets via impairing VM formation in anti-metastatic strategies.
引用
收藏
页码:83 / 96
页数:13
相关论文
共 50 条
  • [41] Role of Twist in vasculogenic mimicry formation in hypoxic hepatocellular carcinoma cells in vitro
    Jin-lu, Ma
    Su-xia, Han
    Qing, Zhu
    Jing, Zhao
    Dan, Zhang
    Li, Wang
    Yi, Lv
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 408 (04) : 686 - 691
  • [42] Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma
    Zhao, Xiulan
    Sun, Baocun
    Liu, Tieju
    Shao, Bing
    Sun, Ran
    Zhu, Dongwang
    Zhang, Yanhui
    Gu, Qiang
    Dong, Xueyi
    Liu, Fang
    Zhao, Nan
    Zhang, Danfang
    Li, Yanlei
    Meng, Jie
    Gong, Wenchen
    Zheng, Yanjun
    Zheng, Xu
    CANCER SCIENCE, 2018, 109 (10): : 3197 - 3208
  • [43] RNA m6A methylation regulators in sepsis
    Zhu, Lin
    Zhang, Hairong
    Zhang, Xiaoyu
    Xia, Lei
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (09) : 2165 - 2180
  • [44] The role of m6A RNA methylation in cancer
    Sun, Ting
    Wu, Ruiyan
    Ming, Liang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 112
  • [45] RNA m6A methylation across the transcriptome
    Sendinc, Erdem
    Shi, Yang
    MOLECULAR CELL, 2023, 83 (03) : 428 - 441
  • [46] Foxq1 promotes metastasis of nasopharyngeal carcinoma by inducing vasculogenic mimicry via the EGFR signaling pathway
    Yunfan Luo
    Jie Wang
    Fan Wang
    Xiong Liu
    Juan Lu
    Xiaoxiao Yu
    Xuemin Ma
    Xiaohong Peng
    Xiangping Li
    Cell Death & Disease, 12
  • [47] Foxq1 promotes metastasis of nasopharyngeal carcinoma by inducing vasculogenic mimicry via the EGFR signaling pathway
    Luo, Yunfan
    Wang, Jie
    Wang, Fan
    Liu, Xiong
    Lu, Juan
    Yu, Xiaoxiao
    Ma, Xuemin
    Peng, Xiaohong
    Li, Xiangping
    CELL DEATH & DISEASE, 2021, 12 (05)
  • [48] m6A RNA Methylation in Cardiovascular Diseases
    Wu, Siyi
    Zhang, Shuchen
    Wu, Xiaoguang
    Zhou, Xiang
    MOLECULAR THERAPY, 2020, 28 (10) : 2111 - 2119
  • [49] N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma
    Cai, Jihao
    Zhou, Minglei
    Xu, Jianxin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [50] N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma
    Jihao Cai
    Minglei Zhou
    Jianxin Xu
    World Journal of Surgical Oncology, 19